Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Trial of Tamoxifen Versus Placebo for the Treatment of Inoperable Hepatocellular Carcinoma

NCT00003424 is registered in ClinicalTrials.gov with National Medical Research Council (NMRC), Singapore as lead sponsor.

NCT NCT00003424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Trial of Tamoxifen Versus Placebo for the Treatment of Inoperable Hepatocellular Carcinoma
Lead sponsor
National Medical Research Council (NMRC), Singapore
Phase
Phase 3
Overall status
Completed
Start date
April 30, 1997
Completion date
August 31, 2009
Enrollment
300 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer